Nava Limited’s board has approved the amalgamation of Nava Healthcare Pte. Ltd with Nava Global Pte. Ltd as part of an internal reorganization of its subsidiary structure. The merger, subject to requisite approvals from relevant regulatory authorities and compliance with Singaporean laws, aims to consolidate the group's investments under a single platform. This strategic move is intended to simplify the holding structure and facilitate long-term value creation for stakeholders.

The transaction involves two wholly owned subsidiaries of Nava Limited operating in Singapore. Nava Global Pte. Ltd (NGPL) holds downstream investments in Energy, Mining and Metals, while Nava Healthcare Pte. Ltd (NHPL) holds investments in healthcare trading and services. The board determined that the amalgamation will allow NGPL to oversee the restructured healthcare investments and pursue strategic business restructuring, including joint ventures for medical offerings in South East Asia.

Financial Overview of Subsidiaries

The financial data for the entities involved in the amalgamation, as at March 31, 2026, is detailed below:

Rationale and Structure

The merger is driven by NGPL’s plan to diversify its investment portfolio across businesses and geographies, leveraging its presence in the APAC region. NHPL’s healthcare business, which has gained traction in Malaysia and Singapore, requires a focused approach and strategic partnerships to ensure sustained positive cash flows. By amalgamating NHPL into NGPL, the group aims to ensure continuity of the existing business while expanding into value-added healthcare services.

Since both entities are wholly owned subsidiaries of Nava Limited, the amalgamation is classified as a related party transaction conducted at arm’s length. Nava Limited’s holding in NHPL will be cancelled, and NGPL will issue new shares to Nava Limited following the amalgamation. Consequently, the merger will not result in any change in the shareholding pattern of the listed entity.

Nava Limited will transfer the final dividend declared for the financial year 2018-19 to the Investor Education and Protection Fund (IEPF) during the financial year 2026-27. The transfer follows the requirement that dividends remaining unclaimed for a period of seven years must be credited to the fund. The corresponding equity shares on which dividends were unclaimed for seven consecutive years will also be transferred to the IEPF authority.

The company has stated that if valid claims are not received on or before August 25, 2026, it will proceed to transfer the liable dividend and shares to the IEPF without further notice. Once transferred, no claim shall lie against the company regarding the unclaimed dividend amount and shares. Shareholders holding shares in physical form will have their original certificates automatically cancelled, while those holding shares in electronic form will see their demat accounts debited.

Claim Process and Shareholder Action

Shareholders whose shares are liable for transfer can claim the shares and dividend from the IEPF authority. This requires submitting an application in the prescribed Form IEPF-5 online after obtaining an Entitlement letter from the company. The company has made full details of such shareholders available on its website.

Compliance and KYC Requirements

In compliance with SEBI circulars dated April 20, 2018, November 03, 2021, March 16, 2023, and November 17, 2023, shareholders are required to furnish email, PAN, and bank account information to the Registrar and Transfer Agent (RTA). Effective from April 1, 2024, shareholders whose KYC details are not updated in their physical folios will be treated as non-KYC accounts.

Key Dates and Contact Information

Shareholders are requested to claim unpaid or unclaimed dividends along with respective shares from the financial year 2018-19 onwards by contacting the company’s RTA immediately.